Literature DB >> 25330145

Prognostic nomogram to predict survival after surgery for synchronous multiple lung cancers in multiple lobes.

Tawee Tanvetyanon1, David J Finley, Thomas Fabian, Marc Riquet, Luca Voltolini, Celalettin Kocaturk, Ayesha Bryant, Lary Robinson.   

Abstract

INTRODUCTION: In the absence of metastatic disease, surgery for synchronous non-small-cell lung cancers involving multiple lobes can be curative. However, there currently exists no reliable prognostic instrument for this patient population after surgery. We undertook an analysis to examine the prognostic significance of adenocarcinoma histology and developed a prognostic nomogram.
METHODS: This study was a pooled analysis of six previously reported datasets. Patients without extra-thoracic metastasis who underwent surgical resection of synchronous lung cancers in multiple lobes were included. Those with small cell cancer, carcinoid tumor, or exclusively carcinoma in situ were excluded. A multivariable Cox proportional hazards regression model was fitted to identify independent survival predictors for nomogram development.
RESULTS: Data from 467 patients were analyzed. Adenocarcinoma was a sole histology in 253 patients (54.2%). Those with exclusively adenocarcinoma histology had a better median survival than their counterparts: 67.4 versus 36.2 months, (p < 0.001). Multivariable analysis incorporating histology, sex, age, maximal T-size, highest N-stage, and laterality demonstrated that having exclusively adenocarcinoma histology independently predicted an improved survival: hazard ratio 0.61 (95% confidence interval: 0.48, 0.78). Other favorable survival predictors were N0, T-size less than or equal to 3 cm, bilateral cancers, age less than 70 years, and women sex. The developed nomogram was well calibrated and demonstrated a moderate to good discrimination with a bootstrap-corrected Harrell C-statistic of 0.70.
CONCLUSION: Several unique features among patients with resected synchronous multiple lung cancers, including the presence of exclusively adenocarcinoma histology, are of prognostic significance. A simple nomogram incorporating these factors can be utilized to predict patient survival with acceptable accuracy.

Entities:  

Mesh:

Year:  2015        PMID: 25330145     DOI: 10.1097/JTO.0000000000000400

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  17 in total

1.  Association between EPHX1 rs1051740 and lung cancer susceptibility: a meta-analysis.

Authors:  Peng Zhang; Youzhi Zhang; Haihua Yang; Wenjing Li; Xiaodong Chen; Feng Long
Journal:  Int J Clin Exp Med       Date:  2015-10-15

2.  Clinical implications of genetic heterogeneity in multifocal pulmonary adenocarcinomas.

Authors:  Tawee Tanvetyanon; Theresa A Boyle
Journal:  J Thorac Dis       Date:  2016-12       Impact factor: 2.895

3.  A Nomogram to Predict Recurrence and Survival of High-Risk Patients Undergoing Sublobar Resection for Lung Cancer: An Analysis of a Multicenter Prospective Study (ACOSOG Z4032).

Authors:  Michael S Kent; Sumithra J Mandrekar; Rodney Landreneau; Francis Nichols; Nathan R Foster; Thomas A DiPetrillo; Bryan Meyers; Dwight E Heron; David R Jones; Angelina D Tan; Sandra Starnes; Joe B Putnam; Hiran C Fernando
Journal:  Ann Thorac Surg       Date:  2016-04-19       Impact factor: 4.330

4.  Deep stacked sparse auto-encoders for prediction of post-operative survival expectancy in thoracic lung cancer surgery.

Authors:  Mohammad Saber Iraji
Journal:  J Appl Biomed       Date:  2019-01-10       Impact factor: 1.797

5.  A nomogram to predict overall survival of patients with early stage non-small cell lung cancer.

Authors:  Jiahui Zhang; Jingyi Fan; Rong Yin; Liguo Geng; Meng Zhu; Wei Shen; Yuzhuo Wang; Yang Cheng; Zhihua Li; Juncheng Dai; Guangfu Jin; Zhibin Hu; Hongxia Ma; Lin Xu; Hongbing Shen
Journal:  J Thorac Dis       Date:  2019-12       Impact factor: 2.895

6.  Expanding TNM for lung cancer through machine learning.

Authors:  Matthew Hueman; Huan Wang; Zhenqiu Liu; Donald Henson; Cuong Nguyen; Dean Park; Li Sheng; Dechang Chen
Journal:  Thorac Cancer       Date:  2021-03-13       Impact factor: 3.500

7.  Development and validation of a preoperative prognostic index independent of TNM stage in resected non-small cell lung cancer.

Authors:  Shogo Kumagai; Satoshi Marumo; Machiko Arita; Keiji Yamanashi; Ryota Sumitomo; Yosuke Otake; Tsuyoshi Shoji; Motonari Fukui; Toshiro Katayama; Norihito Okumura; Cheng-Long Huang
Journal:  BMC Pulm Med       Date:  2017-12-04       Impact factor: 3.317

8.  A Nomogram based on Inflammatory Factors C-Reactive Protein and Fibrinogen to Predict the Prognostic Value in Patients with Resected Non-Small Cell Lung Cancer.

Authors:  Qiuyao Zeng; Ning Xue; Danian Dai; Shan Xing; Xia He; Shibing Li; Yi Du; Chumei Huang; Linfang Li; Wanli Liu
Journal:  J Cancer       Date:  2017-02-25       Impact factor: 4.207

9.  Surgical Outcomes of Synchronous Multiple Primary Non-Small Cell Lung Cancers.

Authors:  Zhirong Zhang; Shugeng Gao; Yousheng Mao; Juwei Mu; Qi Xue; Xiaoli Feng; Jie He
Journal:  Sci Rep       Date:  2016-06-02       Impact factor: 4.379

10.  Prognostic models to predict survival in patients with advanced non-small cell lung cancer treated with first-line chemo- or targeted therapy.

Authors:  Rossana Berardi; Silvia Rinaldi; Matteo Santoni; Thomas Newsom-Davis; Michela Tiberi; Francesca Morgese; Miriam Caramanti; Agnese Savini; Consuelo Ferrini; Mariangela Torniai; Ilaria Fiordoliva; Marc Bower; Stefano Cascinu
Journal:  Oncotarget       Date:  2016-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.